# A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons

> **NCT00079911** · PHASE4 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 7 (actual)

## Conditions studied

- Herpes Genitalis

## Interventions

- **DRUG:** valacyclovir hydrochloride

## Key facts

- **NCT ID:** NCT00079911
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-03-12
- **Primary completion:** 2004-10-15
- **Final completion:** 2004-10-15
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Terminated
- **Last updated:** 2020-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00079911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00079911, "A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00079911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*